[糖尿病足病的发病机制] - Suppr

Suppr

超能文献

[Pathogenesis of diabetic foot disease].

作者信息

Chantelau E

机构信息

Diabetes-Fussambulanz, MNR-Klinik, Düsseldorf.

出版信息

Internist (Berl). 1999 Oct;40(10):994-1001. doi: 10.1007/s001080050429.

DOI:10.1007/s001080050429

PMID:10541625

Abstract

摘要

相似文献

[Pathogenesis of diabetic foot disease].

Internist (Berl). 1999 Oct;40(10):994-1001. doi: 10.1007/s001080050429.

[The diabetic foot].

MMW Fortschr Med. 2006 May 25;148(21):42-4, 46.

[Clinical symptoms and clinical diagnosis in diabetic foot syndrome].

Internist (Berl). 1999 Oct;40(10):1002-8. doi: 10.1007/s001080050430.

[Diabetic foot syndrome--warning signal for the general practitioner].

MMW Fortschr Med. 2010 Nov 4;152(44):43-7; quiz 48. doi: 10.1007/BF03367324.

[General therapy of patients with diabetic foot syndrome].

Internist (Berl). 1999 Oct;40(10):1018-23. doi: 10.1007/s001080050432.

[Angiologic diagnostics and prophylaxis of the diabetic foot syndrome].

MMW Fortschr Med. 2009 May 21;151(21):43-6.

[Diabetic foot syndrome, 2. Methods in differential diagnosis].

MMW Fortschr Med. 2000 Aug 24;142(33-34):43-5.

Prevention of diabetic foot ulceration: new evidences for an old problem.

Endocrine. 2013 Aug;44(1):3-4. doi: 10.1007/s12020-013-9929-7. Epub 2013 Mar 26.

[Diabetic foot: how to avoid therapeutic mistakes].

MMW Fortschr Med. 2013 Oct 24;155(18):63-6. doi: 10.1007/s15006-013-2284-z.

[How to detect diabetics with risk of foot complications].

Diabetes Metab. 1996 Jun;22(3):210-4.

引用本文的文献

Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.

Antimicrob Agents Chemother. 2005 Oct;49(10):4368-71. doi: 10.1128/AAC.49.10.4368-4371.2005.

[Radiological and clinical aspects of diabetic-neuropathic osteoarthropathy].

Orthopade. 2004 Sep;33(9):972-82. doi: 10.1007/s00132-004-0699-z.

[Diabetic complications. Micro and macroangiopathic end-organ damage].

Internist (Berl). 2003 Jul;44(7):840-6, 848-52. doi: 10.1007/s00108-003-0996-3.

Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome.

Antimicrob Agents Chemother. 2003 Jan;47(1):371-4. doi: 10.1128/AAC.47.1.371-374.2003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Pathogenesis of diabetic foot disease].

Internist (Berl). 1999 Oct;40(10):994-1001. doi: 10.1007/s001080050429.

[The diabetic foot].

MMW Fortschr Med. 2006 May 25;148(21):42-4, 46.

[Clinical symptoms and clinical diagnosis in diabetic foot syndrome].

Internist (Berl). 1999 Oct;40(10):1002-8. doi: 10.1007/s001080050430.

[Diabetic foot syndrome--warning signal for the general practitioner].

MMW Fortschr Med. 2010 Nov 4;152(44):43-7; quiz 48. doi: 10.1007/BF03367324.

[General therapy of patients with diabetic foot syndrome].

Internist (Berl). 1999 Oct;40(10):1018-23. doi: 10.1007/s001080050432.

[Angiologic diagnostics and prophylaxis of the diabetic foot syndrome].

MMW Fortschr Med. 2009 May 21;151(21):43-6.

[Diabetic foot syndrome, 2. Methods in differential diagnosis].

MMW Fortschr Med. 2000 Aug 24;142(33-34):43-5.

Prevention of diabetic foot ulceration: new evidences for an old problem.

Endocrine. 2013 Aug;44(1):3-4. doi: 10.1007/s12020-013-9929-7. Epub 2013 Mar 26.

[Diabetic foot: how to avoid therapeutic mistakes].

MMW Fortschr Med. 2013 Oct 24;155(18):63-6. doi: 10.1007/s15006-013-2284-z.

[How to detect diabetics with risk of foot complications].

Diabetes Metab. 1996 Jun;22(3):210-4.

引用本文的文献

Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.

Antimicrob Agents Chemother. 2005 Oct;49(10):4368-71. doi: 10.1128/AAC.49.10.4368-4371.2005.

[Radiological and clinical aspects of diabetic-neuropathic osteoarthropathy].

Orthopade. 2004 Sep;33(9):972-82. doi: 10.1007/s00132-004-0699-z.

[Diabetic complications. Micro and macroangiopathic end-organ damage].

Internist (Berl). 2003 Jul;44(7):840-6, 848-52. doi: 10.1007/s00108-003-0996-3.

Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome.

Antimicrob Agents Chemother. 2003 Jan;47(1):371-4. doi: 10.1128/AAC.47.1.371-374.2003.